Project Details
Description
Targeting virus-specific CAR T cells to lymphoid follicles to achieve durable HIV suppression
Project Summary
There is a need to develop improved treatments for HIV. The studies proposed here will
evaluate a novel treatment strategy that uses patients own T cells to target a reservoir of HIV
within lymphoid tissues. This therapy has the potential to achieve durable suppression of HIV.
Status | Finished |
---|---|
Effective start/end date | 11/13/18 → 10/31/23 |
Funding
- National Institute of Allergy and Infectious Diseases: $725,949.00
- National Institute of Allergy and Infectious Diseases: $714,949.00
- National Institute of Allergy and Infectious Diseases: $749,449.00
- National Institute of Allergy and Infectious Diseases: $714,949.00
- National Institute of Allergy and Infectious Diseases: $714,949.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.